Hikma Pharmaceuticals PLC (LON:HIK)

Hikma Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,540	3,433	4,419	3,955	3,418	5,136
Market Cap Growth	-10.56%	-22.33%	11.74%	15.72%	-33.45%	-11.50%
Enterprise Value	4,808	4,407	5,234	4,766	4,383	5,569
Last Close Price	16.72	14.81	18.43	16.03	13.54	18.90

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	12.79	11.49	15.41	26.52	21.91	16.52
Forward PE	9.36	8.95	10.90	10.80	9.65	14.20
PS Ratio	1.36	1.38	1.77	1.75	1.64	2.72
PB Ratio	1.83	1.77	2.38	2.28	1.92	2.82
P/TBV Ratio	3.33	3.25	4.79	4.59	4.07	4.46
P/FCF Ratio	19.48	19.33	13.87	11.48	10.51	14.11
P/OCF Ratio	9.48	10.60	9.81	8.29	7.77	10.90
PEG Ratio	1.33	1.24	1.66	1.55	2.10	1.49

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	1.85	1.77	2.10	2.11	2.10	2.95
EV/EBITDA Ratio	7.10	7.04	8.26	7.62	7.88	10.50
EV/EBIT Ratio	9.29	9.15	10.67	9.71	10.61	13.44
EV/FCF Ratio	26.55	24.82	16.42	13.83	13.47	15.30

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.77	0.62	0.56	0.54	0.60	0.34
Debt / EBITDA Ratio	2.20	1.88	1.63	1.46	1.88	1.16
Debt / FCF Ratio	8.22	6.71	3.27	2.71	3.27	1.72
Net Debt / Equity Ratio	0.66	0.52	0.47	0.44	0.46	0.16
Net Debt / EBITDA Ratio	1.90	1.62	1.38	1.21	1.48	0.55
Net Debt / FCF Ratio	7.01	5.70	2.74	2.19	2.53	0.80
Asset Turnover	0.60	0.62	0.64	0.63	0.57	0.60
Inventory Turnover	1.69	1.81	1.82	1.76	1.70	1.73
Quick Ratio	1.02	0.91	0.60	0.82	1.05	1.31
Current Ratio	1.98	1.82	1.14	1.57	1.86	2.06
Return on Equity (ROE)	15.41%	16.52%	15.98%	8.81%	8.28%	18.20%
Return on Assets (ROA)	7.47%	7.50%	7.82%	8.54%	7.04%	8.24%
Return on Invested Capital (ROIC)	12.40%	13.77%	14.84%	13.54%	13.60%	15.48%
Return on Capital Employed (ROCE)	15.30%	15.40%	19.50%	18.70%	14.70%	16.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	7.82%	8.70%	6.49%	3.77%	4.57%	6.05%
FCF Yield	5.13%	5.17%	7.21%	8.71%	9.52%	7.09%
Dividend Yield	3.67%	4.00%	3.19%	3.16%	3.00%	1.80%
Payout Ratio	47.55%	46.02%	48.75%	72.10%	66.49%	28.50%
Buyback Yield / Dilution	0.92%	0.36%	-0.51%	1.13%	3.47%	2.10%
Total Shareholder Return	4.62%	4.36%	2.68%	4.29%	6.47%	3.90%

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 22, 2026

Data Sources Report a data error